Understanding the Negative Effects of Bed Rest and Using Exercise as Countermeasure

NCT ID: NCT04964999

Last Updated: 2021-09-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-07-12

Study Completion Date

2022-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Physical activity appears to be an important lifestyle habit to achieve healthy aging by promoting autonomy and quality of life. Interestingly, the dramatic changes that the human body undergoes due to bedrest for illnesses and hospitalization are similar to those seen over decades of normal aging. Bedrest in otherwise healthy older individuals can lead to a reduction of muscle size and strength, changes in bone strength and function of the heart and blood vessels. Bedrest can also lead to changes in keeping proper balance as well as changes in processing and understanding information. All of these factors negatively affect activities of daily living leading to physical function impairment and development of frailty, a clinical condition associated with an increased risk for disease and death.

The purpose of this study is to investigate whether exercise can counteract the negative effects of 2-week head tilt down bed rest on muscle function and metabolism, postural control, bone structure, orthostatic tolerance and cognitive function in adults.

For this study the investigators will recruit 24 healthy men and women between 55 - 65 years of age. All subjects will spend a total of 26 days (5 days of adaption period, 14 days of bed rest with 6 degrees of downward inclination, and 7 days of recovery period) at the McGill University Health Centre (MUHC). During this study, 12 subjects will randomly undergo an exercise intervention as countermeasure during the 14 days of bed rest period and 12 will serve as control.

Each subjects participation in this study will involve 1 telephone call (pre-screening) and 4 visits at the MUHC: 1 screening visit (Visit 1) followed by a 26-day long visit (Visit 2) and 2 follow-up visits (Visit 3 and Visit 4). During Visits 2 - 4 various measurements will be performed to assess sensorimotor control, muscle function and metabolism, bone structure, cardiovascular function, cognitive performance and function, and specimen collection (blood, urine, saliva, feces and muscle tissue).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled study - Participants will be randomly allocated to the exercise or control group.
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Exercise

Participants will perform aerobic and strength exercises for 2 weeks.

Group Type EXPERIMENTAL

Exercise

Intervention Type OTHER

Participants will undergo an exercise program during the 2-week bed rest period.

No exercise

Participants will not perform any exercises.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exercise

Participants will undergo an exercise program during the 2-week bed rest period.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A minimum of 20 and a maximum of 24 non-smoking participants in the age group of 55 to 65 years old, half male and half female.
* Female participants must be menopausal (no menses for at least 1 year (or documented ovariectomy) and a serum FSH above 30 IU/L).
* Height between 158 to 190 cm with a body mass index between 20 to 30 kg/m2.
* Physically and mentally healthy subjects that will have successfully passed the psychological and medical screening appropriate for the age group.
* Participation in at least 2.5 hours of exercise at a moderate to vigorous-intensity aerobic activity per week.
* Willing to be assigned randomly either to the exercise or the control group.

Exclusion Criteria

* Participants must be dementia-free, drug- or alcohol-addiction free, with no history of heart attacks, no thrombosis risk, no severe allergies, no hypocalcaemia, no uric acidemia, no orthostatic intolerance, no vestibular disorders, no considerable musculoskeletal issues, no chronic back pain, no head trauma, no seizures, no ulcers, no renal stones, no gastro-esophageal reflux disease or renal function disorder, no hiatus hernia, no migraines, and no mental illness.
* Electrocardiogram abnormalities
* Anemia
* Low bone mineral density
* Medication requirements that may interfere with the interpretation of the results
* Recent substandard nutritional status
* Claustrophobia
* Special dietary requests (e.g. vegetarian, vegan or some other diet)
* Sedentary people and people that are addicted to exercise
* Metallic implants (pacemakers, ICDs, CRT devices, infusion pumps, cerebral artery aneurysm clips, dental implants, tissue expander etc.), osteosynthesis material
* Given blood in the past 3 months before the onset of the experiment
* Smoked (tobacco and/or marijuana (THC)) within 6 months prior to the start of the study
* Abused drugs, medicine or alcohol within up to 30 days prior to the start of the study
* Participated in another study within 2 months before study onset
Minimum Eligible Age

55 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Canadian Space Agency

UNKNOWN

Sponsor Role collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

Sponsor Role collaborator

Canadian Frailty Network

OTHER

Sponsor Role collaborator

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jose Morais

Professor and Director, Division of Geriatric Medicine, McGill University

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

José A. Morais, MD

Role: PRINCIPAL_INVESTIGATOR

McGill University Health Centre/Research Institute of the McGill University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Royal Victoria Hospital - Glen site

Montreal, Quebec, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Guy Hajj Boutros

Role: CONTACT

514-934-1934 ext. 35016

José A. Morais, MD

Role: CONTACT

514-934-1934 ext. 34499

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Guy Hajj Boutros

Role: primary

514-8934-1934 ext. 35016

References

Explore related publications, articles, or registry entries linked to this study.

Mastrandrea CJ, Hajj-Boutros G, Sonjak V, Hedge ET, Gouspillou G, Hughson RL, Morais JA. Exercise attenuates bed rest-induced increases in insulin resistance while alpha-klotho increases in 55 to 65 year-old women and men. Sci Rep. 2025 Jul 24;15(1):26927. doi: 10.1038/s41598-025-12770-5.

Reference Type DERIVED
PMID: 40707556 (View on PubMed)

Balbim GM, Falck RS, Barha CK, Tai D, Best JR, Hajj-Boutros G, Madden K, Liu-Ambrose T. Exercise counters the negative impact of bed rest on executive functions in middle-aged and older adults: A proof-of-concept randomized controlled trial. Maturitas. 2023 Oct 17;179:107869. doi: 10.1016/j.maturitas.2023.107869. Online ahead of print.

Reference Type DERIVED
PMID: 39491057 (View on PubMed)

Blaber AP, Sadeghian F, Naz Divsalar D, Scarisbrick IA. Elevated biomarkers of neural injury in older adults following head-down bed rest: links to cardio-postural deconditioning with spaceflight and aging. Front Hum Neurosci. 2023 Sep 26;17:1208273. doi: 10.3389/fnhum.2023.1208273. eCollection 2023.

Reference Type DERIVED
PMID: 37822710 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MP-37-2021-7170

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Early In-bed Cycling in Critically Ill Children
NCT02358577 COMPLETED PHASE1/PHASE2
Physical Activity, Sleep and Age
NCT01609764 COMPLETED NA